ELQ-598
Product Specifications
UNSPSC Description
ELQ-598, as a prodrug, is converted into the active drug ELQ-596 upon oral administration. ELQ-598 demonstrates potent parasitic growth inhibition capabilities (IC50= 37 nM). ELQ-598 also shows low toxicity towards human cells (IC50= 19 μM). ELQ-598 can be used for research into babesiosis[1].
Target Antigen
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/elq-598.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC2=C(N=C(C)C(C3=CC=C(C4=CC=C(OC(F)(F)F)C=C4)C=C3)=C2OCOC(OCC)=O)C=C1OC
Molecular Weight
561.93
References & Citations
[1]Vydyam P, et al. Effectiveness of Two New Endochin-like Quinolones, ELQ-596 and ELQ-650, in Experimental Mouse Models of Human Babesiosis. ACS Infect Dis. 2024 Apr 12;10(4):1405-1413.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163483/ELQ-598-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163483/
Clinical Information
No Development Reported
CAS Number
3023709-99-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Cytokeratin 8/18 Antibody (B22.1/B23.1) [DyLight 594]](https://cdn.genprice.uk/genprice/genprice5.png)
NBP3-11504DL594 0.1 mL
Mouse Monoclonal Cytokeratin 8/18 Antibody (B22.1/B23.1) [DyLight 594]
Ask
View Details 
